Literature DB >> 22736917

Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling.

Jing Yang1, Jin-Xiang Zhang, Hui Wang, Guo-Liang Wang, Qing-Gang Hu, Qi-Chang Zheng.   

Abstract

AIM: To investigated the interaction between toll-like receptor 4 (TLR4)-activated hepatoma cells and macrophages in the induction of tumor-immune suppression mediated by CD4+CD25(high) family of transcription factor P3 (FOXP3) regulatory T cells (Tregs).
METHODS: The proportion of FOXP3+ Tregs was identified in peripheral blood and tumor tissues of 60 hepatocellular carcinoma (HCC) patients. TLR4 expression was examined in tumor tissues and cell lines. The correlation was examined between FOXP3+ Tregs in peripheral blood and TLR4 expression of HCC tissues. Following activation of TLR4 in H22 murine hepatoma cells pre-incubated with lipopolysaccharide (LPS) and co-cultured with macrophage cell line RAW246.7, the synthesis of cytokines tumor necrosis factor-α, CCL22, and interleukin (IL)-10 by the two cell lines was detected and analyzed.
RESULTS: FOXP3+ Tregs were enriched in tumor sites, and circulating FOXP3+ Tregs were increased in HCC patients in correlation with multiple tumor foci and up-regulated TLR4 expression in HCC tissues. Semi-quantitative analysis indicated that TLR4 was over-expressed in HCC compared with the matched normal tissues. Cell cultivation experiments indicated that the mRNAs of IL-10 and CCL22 were significantly up-regulated in the RAW246.7 cell line when co-cultured with LPS pre-incubated H22 cells.
CONCLUSION: In hepatoma cell lines, TLR4 may indirectly facilitate the recruitment of Tregs to the tumor site and promote intrahepatic metastasis through its interaction with macrophages.

Entities:  

Keywords:  CD4+CD25highFOXP3+ regulatory T cell; Hepatocellular carcinoma; Macrophage; Toll-like receptor; Tumor immunity

Mesh:

Substances:

Year:  2012        PMID: 22736917      PMCID: PMC3380321          DOI: 10.3748/wjg.v18.i23.2938

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

Review 2.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

Review 3.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

4.  Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.

Authors:  Xiaohong Shen; Na Li; Hui Li; Ti Zhang; Feng Wang; Qiang Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-10       Impact factor: 4.553

5.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

6.  Increase of regulatory T cells in the peripheral blood of cancer patients.

Authors:  Anna Maria Wolf; Dominik Wolf; Michael Steurer; Guenther Gastl; Eberhard Gunsilius; Beatrix Grubeck-Loebenstein
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

Review 7.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

8.  CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.

Authors:  Tetsuro Sasada; Motohide Kimura; Yuka Yoshida; Michiyuki Kanai; Arimichi Takabayashi
Journal:  Cancer       Date:  2003-09-01       Impact factor: 6.860

9.  Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide.

Authors:  Iris Caramalho; Thiago Lopes-Carvalho; Dominique Ostler; Santiago Zelenay; Matthias Haury; Jocelyne Demengeot
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

10.  Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.

Authors:  M Matsuda; F Salazar; M Petersson; G Masucci; J Hansson; P Pisa; Q J Zhang; M G Masucci; R Kiessling
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.

Authors:  Murphy L Y Wan; Hani El-Nezami
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

Review 2.  Roles of Tregs in development of hepatocellular carcinoma: a meta-analysis.

Authors:  Hong-Qiang Zhao; Wei-Min Li; Zhong-Qiou Lu; Yong-Ming Yao
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

3.  CCR2 dependent neutrophil activation and mobilization rely on TLR4-p38 axis during liver ischemia-reperfusion injury.

Authors:  Peng Xu; Junbin Zhang; Hui Wang; Guoliang Wang; Cong-Yi Wang; Jinxiang Zhang
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

Review 4.  Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.

Authors:  Laurissa Ouaguia; Dhafer Mrizak; Sarah Renaud; Olivier Moralès; Nadira Delhem
Journal:  Mediators Inflamm       Date:  2014-11-30       Impact factor: 4.711

5.  Targeted molecular imaging of TLR4 in hepatocellular carcinoma using zwitterionic near-infrared fluorophores.

Authors:  Yuanyuan Ji; Zhidong Wang; Kai Bao; G Kate Park; Homan Kang; Shuang Hu; Eric McDonald; Moon Suk Kim; Satoshi Kashiwagi; Hak Soo Choi
Journal:  Quant Imaging Med Surg       Date:  2019-09

Review 6.  The importance of the nurse cells and regulatory cells in the control of T lymphocyte responses.

Authors:  María Guadalupe Reyes García; Fernando García Tamayo
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

7.  CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Shreya Sharma; Ritu Khosla; Paul David; Archana Rastogi; Ashish Vyas; Dileep Singh; Ankit Bhardwaj; Amrish Sahney; Rakhi Maiwall; Shiv Kumar Sarin; Nirupma Trehanpati
Journal:  Front Immunol       Date:  2015-02-25       Impact factor: 7.561

8.  Expression of CTLA-4 and Foxp3 in peripheral blood T cells of patients with squamous cell laryngeal carcinoma.

Authors:  Katarzyna Starska; Ewa Forma; Iwona Lewy-Trenda; Jan Woś; Paweł Papież; Marcin Mochocki; Piotr Morawski; Renata Kopta; Magdalena Bryś
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07

Review 9.  Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development.

Authors:  Thomas Tu; Magdalena A Budzinska; Annette E Maczurek; Robert Cheng; Anna Di Bartolomeo; Fiona J Warner; Geoffrey W McCaughan; Susan V McLennan; Nicholas A Shackel
Journal:  Int J Mol Sci       Date:  2014-05-27       Impact factor: 5.923

Review 10.  Emerging role of Toll-like receptor 4 in hepatocellular carcinoma.

Authors:  Jing Yang; Min Li; Qi Chang Zheng
Journal:  J Hepatocell Carcinoma       Date:  2015-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.